Brain monitoring may sharpen ECT dosing for severe mental illness

NCT ID NCT07561307

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study will test ways to improve how doctors choose electroconvulsive therapy (ECT) stimulation settings for people with severe depression or catatonia. Researchers will use real-time brain monitoring to measure brain activity and blood flow during ECT. The goal is to find the best method to increase stimulation and understand how different pulse settings affect the brain. Sixty-four participants already receiving ECT will be assigned to either a starting or maintenance group.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Electroconvulsive therapy (ECT) - electrical stimulation under anesthesia
What this could lead to
If successful, this could lead to more personalized and effective ECT dosing, potentially improving treatment outcomes for severe depression and catatonia.
What could go wrong
This is an early-stage, small study (64 participants) focused on refining methods, not testing a new treatment. Results may not apply to all patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CATATONIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Pennsylvania Hospital

    Philadelphia, Pennsylvania, 19146, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.